Predictors of Nabiximols (Sativex®) discontinuation over long-term follow-up: a real-life study

2020 ◽  
Vol 267 (6) ◽  
pp. 1737-1743 ◽  
Author(s):  
Antonio Carotenuto ◽  
Teresa Costabile ◽  
Mario De Lucia ◽  
Marcello Moccia ◽  
Fabrizia Falco ◽  
...  
Keyword(s):  
Real Life ◽  
Life Study ◽  
Long Term Follow Up ◽  
Real Life Study

Long-term follow-up of diabetic macular edema treated with dexamethasone implant: a real-life study

2020 ◽  
Vol 57 (12) ◽  
pp. 1413-1421 ◽  
Author(s):  
Thibaud Mathis ◽  
Théo Lereuil ◽  
Amro Abukashabah ◽  
Nicolas Voirin ◽  
Aditya Sudhalkar ◽  
...  
Keyword(s):  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Real Life ◽  
Dexamethasone Implant ◽  
Life Study ◽  
Long Term Follow Up ◽  
Real Life Study

Real-life study of the effectiveness of a high calorie and high protein formula in the maintenance and improvement of nutritional state in patients with an indication of long-term parenteral nutrition

2021 ◽  
Author(s):  
María D. Ballesteros Pomar ◽  
Patricia Sorribes Carrera ◽  
Maria Amparo Rodriguez Piñera ◽  
Antonio José Blanco Orenes ◽  
Laura Calles Romero ◽  
...  
Keyword(s):  
Parenteral Nutrition ◽  
Real Life ◽  
High Protein ◽  
Nutritional State ◽  
Life Study ◽  
Real Life Study ◽  
High Calorie

scholarly journals Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting

Rheumatology ◽  
2014 ◽  
Vol 54 (7) ◽  
pp. 1170-1176 ◽  
Author(s):  
Maarit Tarkiainen ◽  
Pirjo Tynjälä ◽  
Paula Vähäsalo ◽  
Pekka Lahdenne
Keyword(s):  
Adverse Events ◽  
Real Life ◽  
Biologic Agents ◽  
Real Life Setting ◽  
Long Term Follow Up

Sa1825 ITALIAN REAL-LIFE STUDY EVALUATING THE LONG-TERM EFFECTIVENESS OF VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: THE ELDERLY COHORT

2020 ◽  
Vol 158 (6) ◽  
pp. S-441
Author(s):  
Daniela Pugliese ◽  
Giuseppe Privitera ◽  
Federica Crispino ◽  
Nicolò Mezzina ◽  
Lucienne Pellegrini ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Real Life ◽  
The Elderly ◽  
Life Study ◽  
Inflammatory Bowel ◽  
Real Life Study ◽  
Elderly Cohort

Analysis according to prognostic factors in patients (pts) treated with first-line bevacizumab (BEV) combined with paclitaxel (PAC) for HER2-negative metastatic breast cancer (mBC) in a routine oncology practice study.

2012 ◽  
Vol 30 (15_suppl) ◽  
pp. 1077-1077 ◽  
Author(s):  
Iris Schrader ◽  
Frank Gerhard Foerster ◽  
Andreas Schneeweiss ◽  
Matthias Geberth ◽  
Lars Hahn ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Real Life ◽  
Metastatic Breast ◽  
Progression Free Survival ◽  
Real Life Setting ◽  
Long Term Follow Up ◽  
Practice Study ◽  
Oncology Practice

1077 Background: 1st-line BEV combined with weekly PAC significantly improves progression-free survival (PFS) and response rate (RR) vs PAC alone in HER2-negative mBC, as shown in E2100. We analyzed data from a German routine oncology practice study of 1st-line BEV–PAC according to prognostic factors. Methods: Pts who had received no prior chemotherapy for mBC received BEV–PAC according to the European label. Efficacy and safety were documented for up to 1 y (or until progression, death, or BEV discontinuation if earlier) with additional long-term follow-up. Efficacy was analyzed in clinically important subgroups. Results: Efficacy data were available for 818 pts. The median duration of follow-up was 11.4 mo. The composition of the pt population with respect to the subgroups below was generally similar to the population treated in E2100, except for a higher proportion of pts with visceral disease or metastases in <3 organs. RR was very similar across all subgroups analyzed. Differences in median PFS and OS were generally in line with the differing prognoses according to clinical characteristics. Conclusions: These data suggest that 1st-line BEV–PAC is typically associated with median PFS >9 mo in the real-life setting, irrespective of baseline characteristics. [Table: see text]

scholarly journals Long-Term Therapy with Continuous Positive Airway Pressure in Obstructive Sleep Apnea: Adherence, Side Effects and Predictors of Withdrawal – A ‘Real-Life’ Study

Respiration ◽  
2011 ◽  
Vol 82 (2) ◽  
pp. 155-161 ◽  
Author(s):  
Wolfgang Galetke ◽  
Letizia Puzzo ◽  
Christina Priegnitz ◽  
Norbert Anduleit ◽  
Winfried J. Randerath
Keyword(s):  
Obstructive Sleep Apnea ◽  
Airway Pressure ◽  
Positive Airway Pressure ◽  
Real Life ◽  
Term Therapy ◽  
Life Study ◽  
Obstructive Sleep ◽  
Real Life Study ◽  
Long Term Therapy

scholarly journals 65 Antiphospholipid syndrome long term follow up: real life experience of a single centre

2017 ◽  
Author(s):  
RM Serrano Morales ◽  
G Pons-Estel ◽  
R Quintana ◽  
G Espinosa Garriga ◽  
R Cervera Segura
Keyword(s):  
Antiphospholipid Syndrome ◽  
Life Experience ◽  
Real Life ◽  
Single Centre ◽  
Long Term Follow Up
Sign in / Sign up

Export Citation Format

Share Document